In another study using highly invasive TNBC cell line MDA-MB-231, activation of the cAMP-PKA-CREB pathway in tumor cells induces an M2 macrophage phenotype in the breast cancer TME to impede the antitumor effects of macrophages (Jiang et al, 2022). The gene discussed is CREB1; the disease is breast carcinoma.